Most recently, it's been determined that conolidine and the above derivatives act within the atypical chemokine receptor three (ACKR3. Expressed in very similar places as classical opioid receptors, it binds to the big selection of endogenous opioids. Not like most opioid receptors, this receptor acts to be a scavenger https://anatolb257log6.bloggosite.com/profile